Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gary Tincknell
Observed names:
G. Tincknell,
Tincknell, Gary
Institutions:
University of Wollongong,
Wollongong Hospital,
Illawarra Shoalhaven Local Health District
Observed institutions:
University of Wollongong,
Wollongong Hospital,
Illawarra Shoalhaven Local Health District,
Illawarra Health and Medical Research Institute,
St George Hospital
ORCID:
0000-0003-2611-0075
Observed ORCID:
0000-0003-2611-0075
OpenAlex ID:
A5016332878
Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours
2020
·
Lisi Elizabeth Lim
, David L. Chan
, et al.
·
Oncotarget
·
23
PDF
Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
2021
·
Gary Tincknell
, Ann-Katrin Piper
, et al.
·
Cancers
·
15
PDF
HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis
2022
·
Gary Tincknell
, Asma Naveed
, et al.
·
Cancers
·
10
PDF
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions
2022
·
Nick Pavlakis
, Gary Tincknell
, et al.
·
Therapeutic Advances in Medical Oncology
·
8
EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma
2024
·
Ann-Katrin Piper
, Chelsea Penney
, et al.
·
International Journal of Molecular Sciences
·
7
Safety and dosimetry of 177 Lu-rosopatamab tetraxetanplus SoC in patients with metastatic castration-resistant prostate cancer: Preliminary results from part 1 of phase 3 ProstACT Global study.
2026
·
Pedro C. Barata
, Gary Tincknell
, et al.
·
Journal of Clinical Oncology
·
1
Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer
2024
·
Thomas Hansen
, Jonathon Hill
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
1
PDF
Neoadjuvant chemotherapy induces transient, regimen-specific immune–stromal reprogramming in pancreatic ductal adenocarcinoma
2026
·
Elahe Minaei
, Dezerae Cox
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Safety and Dosimetry of 177Lu-rosopatamab Tetraxetan Plus SoC in Patients with Metastatic Castration-Resistant Prostate Cancer: Preliminary Results from Part 1 of Phase 3 ProstACT Global Study
2026
·
Pedro Barata
, Gary Tincknell
, et al.
·
World Journal of Nuclear Medicine
Adaphostin-induced oxidative stress in oesophageal neuroendocrine carcinoma: a potential therapeutic strategy
2026
·
Chelsea Penney
, Ann-Katrin Piper
, et al.
·
Medical Oncology
PDF
The Impact of Peri-Operative Nutritional Status on Survival in Gastroesophageal Adenocarcinoma
2025
·
Gary Tincknell
, Tamara Bosward
, et al.
·
Current Oncology
488P Tumour buds with mesenchymal phenotype are associated with poorer outcomes in gastric and oesophageal adenocarcinoma
2024
·
G. Tincknell
, A. Naveed
, et al.
·
Annals of Oncology
PDF
An Australian multi-centre experience of the use of peptide receptor radionuclide therapy for bronchial carcinoid tumours
2019
·
L.E. Lim
, D.L. Chan
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
14
Citation count:
65
H-index:
5
I10-index:
3
Year
Topic
Type